ClearPoint Neuro (CLPT) Competitors $10.96 -0.01 (-0.09%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CLPT vs. PDEX, APYX, ICAD, DRIO, STIM, AORT, ESTA, PLSE, BLFS, and BVSShould you be buying ClearPoint Neuro stock or one of its competitors? The main competitors of ClearPoint Neuro include Pro-Dex (PDEX), Apyx Medical (APYX), iCAD (ICAD), DarioHealth (DRIO), Neuronetics (STIM), Artivion (AORT), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), and Bioventus (BVS). These companies are all part of the "medical equipment" industry. ClearPoint Neuro vs. Pro-Dex Apyx Medical iCAD DarioHealth Neuronetics Artivion Establishment Labs Pulse Biosciences BioLife Solutions Bioventus Pro-Dex (NASDAQ:PDEX) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, community ranking, valuation and media sentiment. Which has more risk & volatility, PDEX or CLPT? Pro-Dex has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500. Comparatively, ClearPoint Neuro has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Which has higher valuation & earnings, PDEX or CLPT? Pro-Dex has higher revenue and earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPro-Dex$53.84M2.88$2.13M$1.5430.93ClearPoint Neuro$23.95M12.62-$22.09M-$0.69-15.88 Do analysts rate PDEX or CLPT? Pro-Dex presently has a consensus target price of $52.00, indicating a potential upside of 9.17%. ClearPoint Neuro has a consensus target price of $11.33, indicating a potential upside of 3.41%. Given Pro-Dex's higher possible upside, research analysts plainly believe Pro-Dex is more favorable than ClearPoint Neuro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pro-Dex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00ClearPoint Neuro 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to PDEX or CLPT? In the previous week, ClearPoint Neuro had 1 more articles in the media than Pro-Dex. MarketBeat recorded 1 mentions for ClearPoint Neuro and 0 mentions for Pro-Dex. ClearPoint Neuro's average media sentiment score of 0.35 beat Pro-Dex's score of 0.00 indicating that ClearPoint Neuro is being referred to more favorably in the news media. Company Overall Sentiment Pro-Dex Neutral ClearPoint Neuro Neutral Does the MarketBeat Community believe in PDEX or CLPT? Pro-Dex received 130 more outperform votes than ClearPoint Neuro when rated by MarketBeat users. However, 88.00% of users gave ClearPoint Neuro an outperform vote while only 61.54% of users gave Pro-Dex an outperform vote. CompanyUnderperformOutperformPro-DexOutperform Votes15261.54% Underperform Votes9538.46% ClearPoint NeuroOutperform Votes2288.00% Underperform Votes312.00% Do institutionals & insiders have more ownership in PDEX or CLPT? 15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by insiders. Comparatively, 6.1% of ClearPoint Neuro shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is PDEX or CLPT more profitable? Pro-Dex has a net margin of 9.17% compared to ClearPoint Neuro's net margin of -59.64%. Pro-Dex's return on equity of 16.74% beat ClearPoint Neuro's return on equity.Company Net Margins Return on Equity Return on Assets Pro-Dex9.17% 16.74% 9.98% ClearPoint Neuro -59.64%-62.10%-38.39% SummaryPro-Dex beats ClearPoint Neuro on 10 of the 17 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLPT vs. The Competition Export to ExcelMetricClearPoint NeuroSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$302.60M$4.47B$5.06B$8.89BDividend YieldN/A36.79%4.97%4.06%P/E Ratio-15.8812.8689.0213.30Price / Sales12.6245.351,207.2881.01Price / CashN/A52.2339.1736.03Price / Book10.445.676.085.74Net Income-$22.09M$13.76M$119.07M$225.93M7 Day Performance-2.49%-1.08%-1.84%-1.32%1 Month Performance-17.16%0.58%-3.65%0.60%1 Year Performance84.51%50.91%31.62%26.23% ClearPoint Neuro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLPTClearPoint Neuro0.7546 of 5 stars$10.96-0.1%$11.33+3.4%+88.2%$302.60M$23.95M-15.88110PDEXPro-Dex1.5468 of 5 stars$47.63+5.4%$52.00+9.2%+174.5%$147.35M$53.84M30.93140APYXApyx Medical1.4466 of 5 stars$1.40+9.4%N/A-39.1%$52.70M$48.54M-1.58270ICADiCAD0.526 of 5 stars$1.55-1.3%N/A+16.2%$41.40M$17.32M0.0067Analyst UpgradeDRIODarioHealth1.8622 of 5 stars$0.78-1.3%$4.00+412.8%-31.6%$26.94M$20.35M0.00200STIMNeuronetics2.796 of 5 stars$0.80+6.6%$4.67+481.5%-40.6%$22.92M$71.35M0.00180AORTArtivion1.9659 of 5 stars$27.16+0.9%$31.00+14.1%+92.4%$1.13B$354M0.001,500Positive NewsESTAEstablishment Labs2.1311 of 5 stars$41.81+11.4%$60.60+44.9%+90.0%$1.05B$165.15M0.00960High Trading VolumePLSEPulse Biosciences1.5329 of 5 stars$16.14-5.3%N/A+157.8%$1.05B$700,000.000.00140Positive NewsBLFSBioLife Solutions0.8729 of 5 stars$25.01+11.5%$27.50+10.0%+86.5%$1.04B$143.27M0.00409Analyst ForecastInsider TradeAnalyst RevisionBVSBioventus2.7241 of 5 stars$11.41-1.6%$13.00+13.9%+195.6%$925.98M$555.06M-18.701,200Positive News Related Companies and Tools Related Companies Pro-Dex Competitors Apyx Medical Competitors iCAD Competitors DarioHealth Competitors Neuronetics Competitors Artivion Competitors Establishment Labs Competitors Pulse Biosciences Competitors BioLife Solutions Competitors Bioventus Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CLPT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide vic...Wide Moat Research | SponsoredThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of ...WealthPress | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
